ArcticZymes Technologies ASA (AZT.OL)
NOK 13.58
(-2.3%)
NOK 13.58
(-2.3%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 8.41 Million NOK | -18.69% |
| 2022 | 10.34 Million NOK | -28.5% |
| 2021 | 14.47 Million NOK | 50.83% |
| 2020 | 9.59 Million NOK | -24.83% |
| 2019 | 12.76 Million NOK | 0.0% |
| 2018 | - NOK | 0.0% |
| 2017 | - NOK | 0.0% |
| 2016 | - NOK | 0.0% |
| 2015 | - NOK | 0.0% |
| 2014 | - NOK | 0.0% |
| 2013 | - NOK | 0.0% |
| 2012 | - NOK | 0.0% |
| 2011 | - NOK | 0.0% |
| 2010 | - NOK | 0.0% |
| 2009 | - NOK | 0.0% |
| 2008 | - NOK | 0.0% |
| 2007 | - NOK | 0.0% |
| 2006 | - NOK | 0.0% |
| 2005 | - NOK | 0.0% |
| 2004 | - NOK | 0.0% |
| 2003 | - NOK | 0.0% |
| 2002 | - NOK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 6.05 Million NOK | 0.0% |
| 2024 Q1 | 6.9 Million NOK | 0.0% |
| 2023 Q4 | 8.41 Million NOK | -9.97% |
| 2023 Q2 | 9.99 Million NOK | 1.0% |
| 2023 FY | 8.41 Million NOK | -18.69% |
| 2023 Q1 | 9.89 Million NOK | -4.38% |
| 2023 Q3 | 9.34 Million NOK | -6.48% |
| 2022 Q1 | 12.64 Million NOK | -12.63% |
| 2022 Q3 | 11.17 Million NOK | -13.23% |
| 2022 Q4 | 10.34 Million NOK | -7.4% |
| 2022 FY | 10.34 Million NOK | -28.5% |
| 2022 Q2 | 12.87 Million NOK | 1.86% |
| 2021 FY | 14.47 Million NOK | 50.83% |
| 2021 Q1 | 9.94 Million NOK | 3.6% |
| 2021 Q2 | 17.63 Million NOK | 77.37% |
| 2021 Q3 | 17.6 Million NOK | -0.16% |
| 2021 Q4 | 14.47 Million NOK | -17.78% |
| 2020 Q1 | 14.14 Million NOK | 10.81% |
| 2020 Q3 | 13.74 Million NOK | -0.36% |
| 2020 Q2 | 13.79 Million NOK | -2.48% |
| 2020 Q4 | 9.59 Million NOK | -30.18% |
| 2020 FY | 9.59 Million NOK | -24.83% |
| 2019 Q2 | 17.31 Million NOK | -3.57% |
| 2019 Q3 | 16.67 Million NOK | -3.71% |
| 2019 FY | 12.76 Million NOK | 0.0% |
| 2019 Q4 | 12.76 Million NOK | -23.44% |
| 2019 Q1 | 17.95 Million NOK | 0.0% |
| 2018 Q1 | - NOK | 0.0% |
| 2018 Q2 | - NOK | 0.0% |
| 2018 Q3 | - NOK | 0.0% |
| 2018 FY | - NOK | 0.0% |
| 2018 Q4 | - NOK | 0.0% |
| 2017 FY | - NOK | 0.0% |
| 2017 Q4 | - NOK | 0.0% |
| 2017 Q3 | - NOK | 0.0% |
| 2017 Q2 | - NOK | 0.0% |
| 2017 Q1 | - NOK | 0.0% |
| 2016 Q4 | - NOK | 0.0% |
| 2016 FY | - NOK | 0.0% |
| 2016 Q2 | - NOK | 0.0% |
| 2016 Q1 | - NOK | 0.0% |
| 2016 Q3 | - NOK | 0.0% |
| 2015 Q2 | - NOK | 0.0% |
| 2015 Q3 | - NOK | 0.0% |
| 2015 Q1 | - NOK | 0.0% |
| 2015 Q4 | - NOK | 0.0% |
| 2015 FY | - NOK | 0.0% |
| 2014 Q1 | - NOK | 0.0% |
| 2014 Q3 | - NOK | 0.0% |
| 2014 Q4 | - NOK | 0.0% |
| 2014 Q2 | - NOK | 0.0% |
| 2014 FY | - NOK | 0.0% |
| 2013 Q1 | - NOK | 0.0% |
| 2013 FY | - NOK | 0.0% |
| 2013 Q4 | - NOK | 0.0% |
| 2013 Q3 | - NOK | 0.0% |
| 2013 Q2 | - NOK | 0.0% |
| 2012 Q1 | - NOK | 0.0% |
| 2012 FY | - NOK | 0.0% |
| 2012 Q2 | - NOK | 0.0% |
| 2012 Q3 | - NOK | 0.0% |
| 2012 Q4 | - NOK | 0.0% |
| 2011 Q1 | - NOK | 0.0% |
| 2011 Q2 | - NOK | 0.0% |
| 2011 Q3 | - NOK | 0.0% |
| 2011 Q4 | - NOK | 0.0% |
| 2011 FY | - NOK | 0.0% |
| 2010 Q4 | - NOK | 0.0% |
| 2010 FY | - NOK | 0.0% |
| 2009 FY | - NOK | 0.0% |
| 2008 FY | - NOK | 0.0% |
| 2007 FY | - NOK | 0.0% |
| 2006 FY | - NOK | 0.0% |
| 2005 FY | - NOK | 0.0% |
| 2004 FY | - NOK | 0.0% |
| 2003 FY | - NOK | 0.0% |
| 2002 FY | - NOK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Arctic Bioscience AS | 2.04 Million NOK | -310.693% |
| Aqua Bio Technology ASA | - NOK | -Infinity% |
| BerGenBio ASA | - NOK | -Infinity% |
| Hofseth BioCare ASA | 97.1 Million NOK | 91.335% |
| PCI Biotech Holding ASA | - NOK | -Infinity% |
| Thor Medical ASA | - NOK | -Infinity% |
| Ultimovacs ASA | 1.88 Million NOK | -346.129% |